Pharmacists in Butler, MO Accepting Medicare
6 Pharmacists found. Showing 1 - 6
 Karen Ilene Williams, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 S Fran Ave, Butler, MO 64730 Phone: 660-679-3163 Fax: 660-679-0824 |
 William Mark Jones, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 615 W Nursery St, Butler, MO 64730 Phone: 660-200-7000 |
James David Eckert Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 913 W Fort Scott St, Butler, MO 64730 Phone: 660-679-5002 |
Mr. Rick Lynn Bryson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 S Fran Ave, Butler, MO 64730 Phone: 660-679-3163 Fax: 660-679-0824 |
Brittany Adams Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 913 W Fort Scott St, Butler, MO 64730 Phone: 660-679-5002 Fax: 660-679-5003 |
Daniel Ray Swanson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 S Fran Ave, Butler, MO 64730 Phone: 660-679-3163 Fax: 660-679-0824 |
News Archive
Chemotherapy prior to surgery could improve prognosis in African-American breast cancer patients
Administering chemotherapy to African-American breast cancer patients prior to surgery could improve their prognosis and survival rates from the disease, according to a new study.
Anthera initiates PEARL-SC Phase 2b study of A-623 for lupus
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
Salk scientist Reuben Shaw wins NCI Outstanding Investigator Award
Salk Professor Reuben Shaw has received the National Cancer Institute Outstanding Investigator Award (OIA), which encourages cancer research with breakthrough potential. Shaw, a member of Salk's Molecular and Cell Biology Laboratory and holder of the William R. Brody Chair, will receive $4.2 million in direct funding over the next seven years to further his work.
USPTO issues three standard essential patents to Spherix
Spherix Incorporated - an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that the United States Patent & Trademark Office issued three patents to the Company in the month of August that are part of a standard essential family of patents.
› Verified 9 days ago